Neo Genesis · 14 · Rare Holo · 2000
The raw price over time, with any graded series laid over the same axis — the comparison a grading decision turns on.
Premium22 graded series can be laid over this line — see what the slab did while the raw price moved.Unlock
Every graded price published, next to how many copies exist at that grade.
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶PSA 10 | $6,391 | 80.3× | 9 | 0 |
| ▶PSA 9 | $1,188 $150–$3,050 from sold comps | 14.9× | 269 | 9 |
| ▶PSA 8.5 | $163 unverified | 2.0× | 13 | 278 |
| ▶PSA 8 | $280 $61.00–$695 from sold comps | 3.5× | 893 | 291 |
| ▶PSA 7 | $247 $19.50–$385 from sold comps | 3.1× | 844 | 1,185 |
| ▶PSA 6 | $140 $34.99–$450 from sold comps | 1.8× | 699 | 2,030 |
| ▶PSA 5 | $67.50 $45.00–$185 | 0.8× | 425 | 2,729 |
| ▶PSA 4 | $70.00 $39.95–$148 from sold comps | 0.9× | 97 | 3,154 |
| ▶PSA 3 | $46.15 unverified | 0.6× | 47 | 3,251 |
| ▶PSA 2 | $89.00 | 1.1× | 22 | 3,298 |
| ▶PSA 1 | $117 unverified | 1.5× | 41 | 3,320 |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶BGS 9.5 | $219 unverified | 2.8× | — | — |
| ▶BGS 9 | $620 $335–$880 from sold comps | 7.8× | — | — |
| ▶BGS 8.5 | $450 $300–$650 from sold comps | 5.7× | — | — |
| ▶BGS 8 | $86.99 unverified | 1.1× | — | — |
| ▶BGS 7.5 | $150 | 1.9× | — | — |
| ▶BGS 6 | $40.00 | 0.5× | — | — |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶CGC 10 | $2,075 $590–$3,550 from sold comps | 26.1× | — | — |
| ▶CGC 9.5 | $192 unverified | 2.4× | — | — |
| ▶CGC 9 | $493 $220–$700 from sold comps | 6.2× | — | — |
| ▶CGC 8.5 | $150 $69.99–$499 | 1.9× | — | — |
| ▶CGC 8 | $89.99 $60.00–$220 | 1.1× | — | — |
| ▶CGC 7.5 | $59.99 $59.99–$69.99 | 0.8× | — | — |
| ▶CGC 7 | $33.77 | 0.4× | — | — |
| ▶CGC 6.5 | $39.22 | 0.5× | — | — |
| ▶CGC 6 | $26.06 unverified | 0.3× | — | — |
| ▶CGC 5.5 | $27.41 unverified | 0.3× | — | — |
| ▶CGC 5 | $55.28 | 0.7× | — | — |
| ▶CGC 4 | $25.20 | 0.3× | — | — |
| ▶CGC 3.5 | $16.00 | 0.2× | — | — |
A model's opinion, not investment advice.